Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings

Clinical Genetics

Volumn 64, Issue 1, 2003, Pages 36-47

  Milman, Nils ^a   Pedersen, P ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

Author keywords

Celts; Europe; Hemochromatosis; HFE mutation; Scandinavia; Vikings

Indexed keywords

CYSTEINE; HFE PROTEIN; TYROSINE;

ARTICLE; CONTROLLED STUDY; EUROPE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GEOGRAPHY; HEMOCHROMATOSIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCANDINAVIA; VALIDATION PROCESS;

AMINO ACID SUBSTITUTION; GEOGRAPHY; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; MUTATION; SCANDINAVIA;

EID: 0042131687     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2003.00083.x     Document Type: Article

References (80)

1. Barton JC. A brief history of hemochromatosis. In: Barton JC, Edwards CQ, eds. Hemochromatosis. Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge: Cambridge University Press, 2000: 3-7.
2. Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B. Hémochromatose idiopathique. maladie associée à l'antigène tissulaire HLA-A3? Nouv Presse Med 1975: 4: 1432.
3. Feder JN, Gnirke A, Thomas W et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996: 13: 399-408.
4. Simon M, Alexandre JL, Fauchet R, Genetet B, Bourel M. The genetics of hemochromatosis. Prog Med Genet 1980: 4: 135-168.
5. Fairbanks VF. Hemochromatosis: population genetics. In: Barton JC, Edwards CQ, eds. Hemochromatosis. Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge: Cambridge University Press, 2000: 42-50.
6. Raha-Chowdhury R, Bowen DJ, Stone C et al. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet 1995: 4: 1869-1874.
7. Milman N. Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ, eds. Hemochromatosis. Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge. Cambridge: University Press 2000: 15-41.
8. Smith BN, Kantrowitz W, Grace ND et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor? Hepatology 1997: 25: 1439-1446.
9. Lucotte G. Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis 1998: 24: 433-438.
10. Olsson S, Ritter B. Idiopathic haemochromatosis. Was the ancestor a Danish Viking? Ugeskr Laeger 1983: 145: 831-832.
11. Milman N, Sørensen SA. Idiopathic haemochromatosis. Was the ancestor a Danish Viking? Ugeskr Laeger 1983: 145: 832-833.
12. Alvarez S, Mesa MS, Bandres F, Arroyo E. C282Y and H63D mutation frequencies in a population from central Spain. Dis Markers 2001: 17: 111-114.
13. Andrikovics H, Kalmar L, Bors A et al. Genotype Screening for hereditary hemochromatosis among voluntary blood donors in Hungary. Blood Cells Mol Dis 2001: 27: 334-341.
14. Beckman LE, Saha N, Spitsyn V, Van Landeghem G, Beckman L. Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism. Hum Hered 1997: 47: 263-267.
15. Beris P, Samii K, Darbellay R et al. Iron overload in patients with sideroblastic anaemia is not related to the presence of the haemochromatosis Cys282Tyr and His63Asp mutations. Br J Haematol 1999: 104: 97-99.
16. Borgna-Pignatti C, Solinas A, Bombieri C et al. The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated. Br J Haematol 1998: 103: 813-816.
17. Borot N, Roth M, Malfroy L et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997: 45: 320-324.
18. Braun J, Donner H, Plock K, Rau H, Usadel KH, Badenhoop K. Hereditary haemochromatosis mutations (HFE) in patients with type II diabetes mellitus. Diabetologia 1998: 41: 983-984.
19. Campo S, Restuccia T, Villari D et al. Analysis of haemochromatosis gene mutations in a population from the Mediterranean basin. Liver 2001: 21: 233-236.
20. Cardoso CS, Oliveira P, Porto G et al. Comparative study of the two more frequent HFE mutations (C282Y and H63D): significant different allelic frequencies between the North and South of Portugal. Eur J Hum Genet 2001: 9: 843-848.
21. Cassanelli S, Pignatti E, Montosi G et al. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol 2001: 34: 523-528.
22. Claeys D, Walting M, Julmy F, Wuillemin WA, Meyer BJ. Haemochromatosis mutations and ferritin in myocardial infarction: a case-control study. Eur J Clin Invest 2002: 32 (Suppl. 1): 3-8.
23. Datz C, Lalloz MR, Vogel W et al. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol 1997: 27: 773-779.
24. Distante S, Berg JP, Lande K, Haug E, Bell H. HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 2000: 47: 575-579.
25. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 2001: 358: 1405-1409.
26. Fabrega E, Castro B, Sanchez-Castro L, Benito A, Fernandez-Luna JL, Pons-Romero F. The prevalence of the Cys282Tyr mutation in the hemochromatosis gene in Cantabria in patients diagnosed with hereditary hemochromatosis. Med Clin (Barc) 1999: 112: 451-453.
27. Gimferrer E, Nomdedeu J, Gich I, Barcelo MJ, Baiget M. Prevalence of hemochromatosis related HFE gene mutations in patients with acute mycloid leukemia. Leuk Res 1999: 23: 597-598.
28. Gottschalk R, Seidl C, Schilling S et al. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in German patients with hereditary haemochromatosis. Eur J Immunogenet 2000: 27: 129-134.
29. Grove J, Daly AK, Burt AD et al. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 1998: 43: 262-266.
30. Guix P, Picornell A, Parera M et al. Prevalence of the C282Y mutation for haemochromatosis on the Island of Majorca [In Process Citation]. Clin Genet 2000: 58: 123-128.
31. Hellerbrand C, Bosserhoff AK, Seegers S et al. Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique. Scand J Gastroenterol 2001: 36: 1211-1216.
32. Hohler T, Leininger S, Kohler HH, Schirmacher P, Galle PR. Heterozygosity for the hemochromatosis gene in liver diseases - prevalence and effects on liver histology. Liver 2000: 20: 482-486.
33. Hrachovinova I, Rypackova B, Vyoral D. Lack of association between hemochromatosis and factor V Leiden mutations in the Czech population. Thromb Haemost 1999: 82: 1197-1198.
34. Ivanova A, von Ahsen N, Adjarov D, Krastev Z, Oellerich M, Wieland E. C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in Bulgaria. Hepatology 1999: 30: 1531-1532.
35. Jackson HA, Carter K, Darke C et al. HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 2001: 114: 474-484.
36. Jezequel P, Bargain M, Lellouche F, Geffroy F, Dorval I. Allele frequencies of hereditary hemochromatosis gene mutations in a local population of west Brittany. Hum Genet 1998: 102: 332-333.
37. Jouanolle AM, Fergelot P, Raoul ML et al. Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis? Ann Genet 1998: 41: 195-198.
38. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999: 116: 127-134.
39. Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C. The influence of hemochromatosis mutations on iron overload of thalassemia major. Haematologica 1999: 84: 799-803.
40. Mercier G, Bathelier C, Lucotte G. Frequency of the C282Y mutation of hemochromatosis in five French populations. Blood Cells Mol Dis 1998: 24: 165-166.
41. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282y H63D mutations. Genet Test 2000: 4: 183-198.
42. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997: 34: 275-278.
43. Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Nørgaard-Pedersen B, Robson KJ. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 1999: 13: 154-159.
44. Merryweather-Clarke AT, Worwood M, Parkinson L et al. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population. Br J Haematol 1998: 101: 369-373.
45. Miedzybrodzka Z, Loughlin S, Baty D et al. Haemochromatosis mutations in North-East Scotland. Br J Haematol 1999: 106: 385-387.
46. Mikelsaar AV, Beckman L, Tasa G, Paerlist P. Regional differences of hemochromatosis mutations in Estonian population [Abstract]. Eur J Hum Genet 1999: 7: 595.
47. Moczulski DK, Grzeszczak W, Gawlik B. Frequency of the hemochromatosis C282Y and H63D mutations in a Polish population of Slavic origin. Med Sci Monit 2001: 7: 441-443.
48. Moreno L, Vallcorba P, Boixeda D, Cabello P, Bermejo F, San Roman C. The usefulness of the detection of Cys282Tyr and His63Asp mutations in the diagnosis of hereditary hemochromatosis. Rev Clin Esp 1999: 199: 632-636.
49. Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999: 93: 2502-2505.
50. Murphy S, Curran MD, McDougall N, Callender ME, O'Brien CJ, Middleton D. High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population. Implications for haemochromatosis. Tissue Antigens 1998: 52: 484-488.
51. Nielsen P, Carpinteiro S, Fischer R, Cabeda JM, Porto G, Gabbe EE. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol 1998: 103: 842-845.
52. Papanikolaou G, Politou M, Terpos E, Fourlemadis S, Sakellaropoulos N, Loukopoulos D. Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells Mol Dis 2000: 26: 163-168.
53. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998: 114: 996-1002.
54. Pozzato G, Zorat F, Nascimben F et al. Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry. Eur J Hum Genet 2001: 9: 445-451.
55. Racchi O, Mangerini R, Rapezzi D et al. Mutations of the HFE gene and the risk of hepatocellular carcinoma. Blood Cells Mol Dis 1999: 25: 350-353.
56. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997: 349: 321-323.
57. Roest M, van der Schouw YT, de Valk B et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 1999: 100: 1268-1273.
58. Ryan E, O'keane C, Crowe J. Hemochromatosis in Ireland and HFE. Blood Cells Mol Dis 1998: 24: 428-432.
59. Sampietro M, Piperno A, Lupica L et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998: 27: 181-184.
60. Sanchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 1998: 29: 725-728.
61. Simonsen K, Dissing J, Rudbeck L, Schwartz M. Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet 1999: 63: 193-197.
62. Steffensen R, Varming K, Jersild C. Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers. Tissue Antigens 1998: 52: 230-235.
63. Szakony S, Balogh I, Muszbek L. The frequency of the haemochromatosis C282Y mutation in the ethnic Hungarian and Romany populations of Eastern Hungary. Br J Haematol 1999: 107: 464-465.
64. Tordai A, Andrikovics H, Kalmar L et al. High frequency of the haemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation. J Med Genet 1998: 35: 878-879.
65. Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in Eastern Finland. Circulation 1999: 100: 1274-1279.
66. Undlien DE, Bell H, Heier HE, Akselsen HE, Thorsby E. Genetic diagnostic test for hemochromatosis. Tidsskr Nor Laegeforen 1998: 118: 238-240.
67. Willis G, Jennings BA, Goodman E, Fellows IW, Wimperis JZ. A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England. Blood Cells Mol Dis 1997: 23: 288-291.
68. Zdarsky E, Horak J, Stritesky J, Heirler F, Hemochromatosis. Determination of the C282Y mutation frequency in the population of the Czech Republic and sensitivity of hemochromatosis detection using Guthrie cards. Cas Lek Cesk 1999: 138: 497-499.
69. James S. Exploring the World of the Celts. London: Thames & Hudson, 1993.
70. Kaul F. The Gundestrup Cauldron. Copenhagen: Nyt Nordisk Forlag Arnold Busck A/S, 1991.
71. Kaul F. When the Weapons were Stilled. The Hjortspring Find. Copenhagen: Nyt Nordisk Forlag Arnold Busck A/S, 1988.
72. Roesdahl E. The Vikings, 2nd edn. London: Penguin Books, 1998: 187-292.
73. Brown RA. The Normans, 2nd edn. Woodbridge: Boydell Press, 1997.
74. Bates D. West Francia: the Northern Principalities In: Reuter T, eds. The New Cambrigde Medieval History, Vol. 3. Cambrigde: Cambrigde University Press, 1999: 398-455.
75. Bates D. Normandy Before 1066. London: Longman, 1982.
76. Musset L, Les invasions. Le Second Assaut Contre l'Europe Chrétienne VII-IX Siécles. Paris: Presses Universitaire de France, 1971.
77. Lund N. De hærger og de brænder. Danmark Og England I Vikingetiden, 2nd edn. Copenhagen: Gyldendal, 1997.
78. Price NS. The Vikings in Brittany. In: Saga-book of the Viking Society for Northern Research, Vol. 22, part 6. London: University College London, 1989: 319-440.
79. Ajioka RS, Jorde LB, Gruen JR et al. Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 1997: 60: 1439-1447.
80. Thomas W, Fullan A, Loeb DB, McClelland EE, Bacon BR, Wolff RK. A haplotype and linkage-disequilibrium analysis of the hereditary hemochromatosis gene region. Hum Genet 1998: 102: 517-525.